Watch These Stocks: Westpac Banking Corporation (NYSE:WBK), Amyris (NASDAQ:AMRS), Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), Cymabay Therapeutics (NASDAQ:CBAY)

New Residential Investment Corp. (NYSE:NRZ) shares remains unchanged in last trading session and ended the day at $12.41. NRZ Gross Margin is 61.30% and its has a return on assets of 3.10%. New Residential Investment Corp. (NYSE:NRZ) quarterly performance is -15.50%.

New Residential Investment Corp. (NYSE:NRZ) on Tuesday reported third-quarter net income of $54.5 million. The New York-based company said it had profit of 24 cents per share. Earnings, adjusted for non-recurring costs, came to 49 cents per share. The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of 49 cents per share.

Westpac Banking Corporation (NYSE:WBK) ended the last trading day at $22.61. Company weekly volatility is calculated as 1.27% and price to cash ratio as 0.90. Westpac Banking Corporation (NYSE:WBK) showed a weekly performance of -0.83%.

Westpac bank Banking Corporation (NYSE:WBK) will offer more than 10,600 insurance customers refunds for premiums paid for cover they did not need. Westpac had charged some customers for loan protection when they did not have a loan or did not want to be covered, the Australian Securities and Investments Commission said on 29 October .

On 03 November, Amyris, Inc. (NASDAQ:AMRS) shares advanced 6.98% and was closed at $1.84. AMRS EPS growth in last 5 year was 14.90%. Amyris, Inc. (NASDAQ:AMRS) year to date (YTD) performance is -10.68%.

Amyris, Inc. (NASDAQ:AMRS) will report financial results for the third quarter ended September 30, 2015 after market close on Thursday, November 5, 2015. The Company will hold its quarterly conference call to discuss these results, as well as provide an update on the Company’s business and outlook, at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, November 5, 2015.

Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) shares decreased -0.81% in last trading session and ended the day at $141.68. JAZZ Gross Margin is 91.70% and its has a return on assets of 8.00%. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) quarterly performance is -26.17%.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced that it will report its 2015 third quarter financial results on Monday, November 9, 2015, after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST/9:30 p.m. GMT to discuss 2015 third quarter financial results and provide a business and financial update.

Cymabay Therapeutics, Inc. (NASDAQ:CBAY) caters to the Healthcare space. Its weekly performance is -8.02%. On the last day of trading company shares ended up at $1.49. Cymabay Therapeutics, Inc. (NASDAQ:CBAY) distance from 50-day simple moving average (SMA50) is 6.86%.

LifeSci Capital, LLC, announced that it has initiated coverage of CymaBay Therapeutics, Inc. (NASDAQ:CBAY) clinical-stage biopharmaceutical company developing therapies for metabolic and orphan diseases.